Rs.263 Million API & Intermediates Mfg. Unit in Vadodara, Gujarat
A major pharmaceutical player is investing over Rs. 3,000 million to establish a high-capacity aseptic manufacturing hub in Vadodara. The project scales sterile injectable production to 10 million units annually, integrating advanced delivery systems like pre-filled syringes and microspheres. Construction begins in May 2026, bridging the gap between R&D and commercial-scale API manufacturing.
View project